Sebaceous carcinoma of the male breast
Clinical Oncology Research and Reports · 2020
DOI: 10.31579/2693-4787/019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oncology Research and Reports, 2020. Verfasst von Satyajeet Rath.
Abstract (Originalsprache)
Sebaceous carcinoma of the male breast is an exceedingly rare occurrence. Literature is inadequate about the prognosis and treatment of such malignancies. We report histo-pathological and immuno-histochemical (IHC) findings in a case of sebaceous carcinoma of breast of a 60-year-old male. An initial biopsy suggested sebaceous carcinoma. Total mastectomy was performed, followed by local radiotherapy and adjuvant chemotherapy. The receptor status was triple negative. Pan cytokeratin and epithelial membrane antigen were positive, whereas S-100 was focally positive and HMB-45 and Melan A were negative. IHC is central to diagnosis and differentiation of these rare kind of tumours from the common invasive ductal carcinomas. The exact line of treatment following excision of the tumour is unclear. Local radiotherapy is generally indicated, whereas the role of adjuvant chemotherapy is uncertain. Wider reporting of such cases will help in widening the horizon of prognosis and management of these tumours.
Zitieren
APA
Rath, S. (2020). Sebaceous carcinoma of the male breast. Clinical Oncology Research and Reports. https://doi.org/10.31579/2693-4787/019
Vancouver
Rath S. Sebaceous carcinoma of the male breast. Clinical Oncology Research and Reports. 2020. doi:10.31579/2693-4787/019
BibTeX
@article{Rath2020,
author = {Rath, Satyajeet},
title = {Sebaceous carcinoma of the male breast},
journal = {Clinical Oncology Research and Reports},
year = {2020},
doi = {10.31579/2693-4787/019}
}
EUVIMED